2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Glenn N. Levine, Eric R. Bates, John A. Bittl, Ralph G. Brindis, Stephan D. Fihn, Lee A. Fleisher, Christopher B. Granger, Richard A. Lange, Michael J. Mack, Laura Mauri, Roxana Mehran, Debabrata Mukherjee, L. Kristin Newby, Patrick T. O'Gara, Marc S. Sabatine, Peter K. Smith, Sidney C. Smith, Jonathan L. Halperin, Glenn N. Levine, Sana M. Al-KhatibKim K. Birtcher, Biykem Bozkurt, Ralph G. Brindis, Joaquin E. Cigarroa, Lesley H. Curtis, Lee A. Fleisher, Federico Gentile, Samuel Gidding, Mark A. Hlatky, John S. Ikonomidis, José A. Joglar, Susan J. Pressler, Duminda N. Wijeysundera

Research output: Contribution to journalArticlepeer-review

228 Scopus citations
Original languageEnglish (US)
Pages (from-to)1243-1275
Number of pages33
JournalJournal of Thoracic and Cardiovascular Surgery
Issue number5
StatePublished - Nov 1 2016


  • AHA
  • P2Y inhibitor
  • Scientific Statements
  • acute coronary syndrome
  • aspirin
  • coronary artery disease
  • coronary stents
  • dual antiplatelet therapy (DAPT)
  • focused update
  • stable ischemic heart disease

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this